3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Neuroendocrine Tumors
10
Meningioma
4
Gastro-enteropancreatic neuroendocrine tumor
3
Prostatic Neoplasms
2
Pheochromocytoma
2
Paraganglioma
2
Pancreatic Neoplasms
2
Neuroblastoma
2
Neoplasms, Germ Cell and Embryonal
2
Medulloblastoma
2
Glioma
2
Ependymoma
2
Adenoma, Islet Cell
2
Stomach Neoplasms
1
Sarcoma, Synovial
1
Recurrence
1
Pancreatic Diseases
1
Osteosarcoma
1
Neuroectodermal Tumors
1
Neoplasms, Nerve Tissue
1
Neoplasms by Site
1
Neoplasms by Histologic Type
1
Neoplasms
1
Metastatic Digestive System Neuroendocrine Tumor G1
1
Intestinal Neoplasms
1
Intestinal Diseases
1
Hypertension
1
Glioblastoma
1
Gastrointestinal Neoplasms
1
Gastrointestinal Diseases
1
Interventions
pembrolizumab
9
Nivolumab
5
aldesleukin
2
Specimen Handling
2
Magnetic Resonance Spectroscopy
2
Ipilimumab
2
Interleukin-2
2
Cyclophosphamide
2
Biopsy
2
sargramostim
1
relatlimab
1
regorafenib
1
prednylidene
1
lutetium Lu 177 dotatate
1
fludarabine phosphate
1
fludarabine
1
deltacortene
1
avelumab
1
aflibercept
1
X-Rays
1
Sirolimus
1
Sentinel Lymph Node Biopsy
1
Radiotherapy
1
Prednisone
1
Predictive Learning Models
1
Paclitaxel
1
Opdualag
1
NEO212
1
Lidocaine, Prilocaine Drug Combination
1
Laparoscopy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Carcinoma, Merkel Cell
×
lutetium Lu 177 dotatate
×
Clear all
NCT05583708
2026-04-22
iPRRT
Weill Medical College of Cornell University
Phase 2
Recruiting
18 enrolled